HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prostaglandin F2 alpha and E2 release by peritoneum with and without endometriosis.

Abstract
Peritoneal endometriotic implants and adjacent normal peritoneum from five patients were analyzed for prostaglandin (PG) release. Each tissue biopsy was incubated using medium 199 in triplicate at 37 degrees C for six hours, and PGF2 alpha and PGE2 concentrations were measured in the incubation medium every two hours. This study demonstrates that peritoneum involved with endometriosis releases significantly more PGF2 alpha and PGE2 (P less than .05) than adjacent normal peritoneum, and suggests that peritoneal endometriotic implants may be a source of the elevated peritoneal fluid PG levels previously reported in patients with endometriosis.
AuthorsF D De Leon, R Vijayakumar, C V Rao, M Yussman
JournalInternational journal of fertility (Int J Fertil) 1988 Jan-Feb Vol. 33 Issue 1 Pg. 48-51 ISSN: 0020-725X [Print] United States
PMID2896174 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Prostaglandins E
  • Prostaglandins F
  • Dinoprost
  • Dinoprostone
Topics
  • Analysis of Variance
  • Dinoprost
  • Dinoprostone
  • Endometriosis (physiopathology)
  • Female
  • Humans
  • Peritoneal Diseases (physiopathology)
  • Peritoneum (metabolism, physiology)
  • Prostaglandins E (metabolism, physiology)
  • Prostaglandins F (metabolism, physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: